<DOC>
	<DOCNO>NCT02818738</DOCNO>
	<brief_summary>Idiopathic Nephrotic Syndrome sensitive steroid 90 % child . However , patient relapse become steroid-dependant , long last relapse course . The aim study assess efficiency 6-months levamisole course , give early first remission , maintain relapse-free course 12 month .</brief_summary>
	<brief_title>Efficiency Levamisole Maintaining Remission After First Flare Steroid Sensitive Nephrotic Syndrome Children</brief_title>
	<detailed_description>Introduction ( INS ) likely primal immune disorder . Initial treatment relies steroid therapy . NS sensitive steroid 90 % case , excellent renal prognosis . Nevertheless , 80 % patient steroid sensitive NS relapse , 60 % within first year . 2/3 experience steroid dependency , long last relapse course . These patient require immunosuppressive drug steroid spar agent , mycophenolate , cyclophosphamide , calcineurin inhibitor rituximab . Morbidity high related duration disease , sometimes adulthood , treatment side effect . Levamisole immunomodulator use thirty year treatment steroid-dependent frequently relapse NS . Its major advantage immunomodulatory action lower reversible toxicity . Exact physiopathology INS levamisole action remain unknown . Nevertheless , make hypothesis early treatment levamisole may enhance efficiency modify disease 's course . This first trial ass efficiency levamisole increase duration remission first manifestation INS . Design : - A multicenter , double-blind , placebo-controlled , randomised clinical trial . - 38 center participate recruitment : 3 Pediatric Nephrology unit 35 General Pediatric unit . - 20 center participate randomize phase . Sample size : 156 patient , 78 group Treatment group : 1 . Levamisole Hydrochloride Dosage : 5 , 10 , 25 et 50mg . Dosage form : oral tablet Posology : 2.5 mg/kg alternate day maximum 150mg . Treatment duration : 6 month 2. placebo : matching verum Assessment : Study visit inclusion , M1 ( randomisation ) , M3 , M6 , M9 , M12 . Supplementary visit relapse occur . Statistical procedure Analysis efficiency perform intention treat population . Analysis tolerance perform randomized patient receive least one dose treatment . No intermediary analysis plan .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Levamisole</mesh_term>
	<criteria>Age 12 month &lt; age &lt; 16 year Child 's weight â‰¥ 7 Kg Diagnosis first manifestation INS define : hypoalbuminemia &lt; 25g/l , proteinuria &gt; 0.20 g/mmol urinary creatinine normal C3 fraction complement Written inform consent parent Anteriority INS Pregnancy , breast feeding plan pregnancy study Patients neutropenia , convulsion hepatic disease Diabetes malignancy</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Idiopathic nephrotic syndrome</keyword>
	<keyword>Steroid sensitive nephrotic syndrome</keyword>
	<keyword>Levamisole</keyword>
	<keyword>Prednisone</keyword>
	<keyword>Children</keyword>
</DOC>